Unlabelled: Unfractionated heparin (UFH) is the most widely used anticoagulant in hospitalized patients. The therapeutic range (TR) was defined in adults according to the prolongation of the activated Partial Thromboplastin Time (aPTT). However, the recommendation is to maintain a therapeutic range with anti-factor Xa assay (antiFXa). As this technique is more complex to perform and less available, it is recommended to make local correlation curves of aPTT with antiFXa.
Objective: to determine the correlation between the values of aPTT and antiFXa in patients treated with UFH.
Patients And Method: 52 patients between 2 days to 14 years of age hospitalized in the Pediatric Critical Patient Unit were recruited. They received treatment with UFH in continuous infusion for at least 24 hours. aPTT and antiFXa tests were performed according to the moment of anticoagulation. To evaluate the concordance of the levels of aPTT with those of antiFXa, the Kappa statistical coefficient of Landis and Koch was used.
Results: 105 samples were collected from 52 patients. The overall concordance was 0.452 (moderate correlation). In patients aged < 1 month (n = 40), a considerable correlation was evident (r = 0.617); in those from 1 month to < 6 months (n = 18) and 6 months - < 12 months with aPTT < 120 seconds (n = 11), also showed a considerable correlation (r = 0.636 and 0.615, respec tively), while in those aged > 12 months (n = 37) with aPTT < 120 seconds, a moderate correlation was evident (r = 0.454).
Conclusion: In our population, there is a moderate correlation between the values of aPTT and antiFXa.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.32641/andespediatr.v93i6.4271 | DOI Listing |
Curr Pharm Des
October 2024
Institute of Clinical Pharmacology, Peking University First Hospital, Beijing, China.
Andes Pediatr
December 2022
Departamento de Pediatría, Pontificia Universidad Católica de Chile, Santiago, Chile.
Unlabelled: Unfractionated heparin (UFH) is the most widely used anticoagulant in hospitalized patients. The therapeutic range (TR) was defined in adults according to the prolongation of the activated Partial Thromboplastin Time (aPTT). However, the recommendation is to maintain a therapeutic range with anti-factor Xa assay (antiFXa).
View Article and Find Full Text PDFZhonghua Yi Xue Za Zhi
January 2023
Center of Respiratory Medicine, China-Japan Friendship Hospital; National Clinical Research Center for Respiratory Diseases; Department of Pulmonary and Critical Care Medicine, Beijing 100029, China.
Heparin resistance is becoming a hot issue of clinical concern. In critically ill patients, heparin resistance can lead to failure of anticoagulation therapy or increase the risk of major bleeding. Prompt recognition of heparin resistance can help to precisely adjust heparin dosage and avoid deterioration and adverse events.
View Article and Find Full Text PDFClin Chim Acta
January 2023
Laboratory of Biochemistry and Hematology, Onze-Lieve-Vrouw Ziekenhuis, Moorselbaan 164, 9300 Aalst, Belgium.
Background: Direct oral anticoagulants (DOACs) may cause falsely increased levels of antithrombin (AT) activity depending on the AT activity method and the specific target of the DOAC. Activated carbon (AC) has proven to remove DOAC interference on PT, aPTT and LA assays. We evaluate whether AC could be useful to resolve DOAC interference on AT assays.
View Article and Find Full Text PDFJ Clin Lab Anal
October 2022
Department of Pathology, Phramongkutklao College of Medicine, Bangkok, Thailand.
Background: The high concentrated thrombin time (hcTT), a thrombin time modified by increasing the thrombin concentration, is a possible alternative assay to activated partial thromboplastin time (aPTT) in unfractionated heparin (UFH) monitoring. This study aimed to determine the optimal thrombin concentration used in the hcTT assay for UFH monitoring.
Methods: A total of 30 blood samples obtained from healthy volunteers were included in this study.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!